Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions is a research paper published in Journal of Neuro-Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
BLRD VA
Grant: I01 BX005842
NCI NIH HHS
Grant: R01 CA277728
NCI NIH HHS
Grant: U01 CA248226
NCI NIH HHS
Grant: R01 CA264017
MeSH Terms
Keywords
Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions
Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions